Asan Multivessel Registry
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with multivessel disease from 1995 in Asan Medical Center
Age 19 and more
Disqualifiers
For prospective cohort, not agreeing to participate with written informed consent form
Trial population
Patients with multivessel disease from 1995 in Asan Medical Center
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Treatment
Other intervention
Treatment groups
25,000 Participants
are divided into 1 treatment groupGroup A: Multivessel1 intervention
Trial outcomes
Primary outcomes
1
composite event
death, myocardial infarction, stroke, revascularization
Time frame
1yearSecondary outcomes
1
Death
Time frame
1year2
Myocardial Infarction
Time frame
1year3
Stroke
Time frame
1year4
Revascularization
Time frame
1yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov